Genetic variation in five genes important in telomere biology and risk for breast cancer

被引:0
|
作者
S A Savage
S J Chanock
J Lissowska
L A Brinton
D Richesson
B Peplonska
A Bardin-Mikolajczak
W Zatonski
N Szeszenia-Dąbrowska
M Garcia-Closas
机构
[1] Clinical Genetics Branch,Division of Cancer Epidemiology and Genetics
[2] National Cancer Institute,Division of Cancer Epidemiology and Genetics
[3] National Institutes of Health,Department of Cancer Epidemiology and Prevention
[4] Pediatric Oncology Branch,Division of Cancer Epidemiology and Genetics
[5] Center for Cancer Research,Department of Epidemiology
[6] National Cancer Institute,undefined
[7] National Institutes of Health,undefined
[8] Core Genotyping Facility,undefined
[9] National Cancer Institute,undefined
[10] National Institutes of Health,undefined
[11] Cancer Center and M Sklodowska-Curie Institute of Oncology,undefined
[12] Hormonal and Reproductive Epidemiology Branch,undefined
[13] National Cancer Institute,undefined
[14] National Institutes of Health,undefined
[15] Nofer Institute of Occupational Medicine,undefined
来源
British Journal of Cancer | 2007年 / 97卷
关键词
breast cancer; telomere; haplotype; single nucleotide polymorphism;
D O I
暂无
中图分类号
学科分类号
摘要
Telomeres, consisting of TTAGGG nucleotide repeats and a protein complex at chromosome ends, are critical for maintaining chromosomal stability. Genomic instability, following telomere crisis, may contribute to breast cancer pathogenesis. Many genes critical in telomere biology have limited nucleotide diversity, thus, single nucleotide polymorphisms (SNPs) in this pathway could contribute to breast cancer risk. In a population-based study of 1995 breast cancer cases and 2296 controls from Poland, 24 SNPs representing common variation in POT1, TEP1, TERF1, TERF2 and TERT were genotyped. We did not identify any significant associations between individual SNPs or haplotypes and breast cancer risk; however, data suggested that three correlated SNPs in TERT (−1381C>T, −244C>T, and Ex2-659G>A) may be associated with reduced risk of breast cancer among individuals with a family history of breast cancer (odds ratios 0.73, 0.66, and 0.57, 95% confidence intervals 0.53–1.00, 0.46–0.95 and 0.39–0.84, respectively). In conclusion, our data do not support substantial overall associations between SNPs in telomere pathway genes and breast cancer risk. Intriguing associations with variants in TERT among women with a family history of breast cancer warrant follow-up in independent studies.
引用
收藏
页码:832 / 836
页数:4
相关论文
共 50 条
  • [31] Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study
    Beeghly-Fadiel, Alicia
    Shu, Xiao-Ou
    Lu, Wei
    Long, Jirong
    Cai, Qiuyin
    Xiang, Yong-Bing
    Zheng, Ying
    Zhao, Zhongming
    Gu, Kai
    Gao, Yu-Tang
    Zheng, Wei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (01) : 33 - 41
  • [32] Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk
    Rongrong Wei
    Frank T.De Vilbiss
    Wanqing Liu
    [J]. Journal of Genetics and Genomics, 2015, 42 (10) : 549 - 561
  • [33] Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk
    Wei, Rongrong
    DeVilbiss, Frank T.
    Liu, Wanqing
    [J]. JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (10) : 549 - 561
  • [34] Genetic variation in the major mitotic checkpoint genes and risk of breast cancer: a multigenic study on cancer susceptibility
    Wang, Ping
    Wang, Yong
    Yan, Haichao
    Xie, Qiuping
    Zhao, Liang
    Xu, Shaoming
    Zhao, Qunzi
    [J]. TUMOR BIOLOGY, 2014, 35 (07) : 6701 - 6705
  • [35] Genetic variation in adipokine genes and risk of colorectal cancer
    Pechlivanis, Sonali
    Bermejo, Justo Lorenzo
    Pardini, Barbara
    Naccarati, Alessio
    Vodickova, Ludmila
    Novotny, Jan
    Hemminki, Kari
    Vodicka, Pavel
    Foersti, Asta
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (06) : 933 - 940
  • [36] Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk
    Genevieve M. Monsees
    Peter Kraft
    Stephen J. Chanock
    David J. Hunter
    Jiali Han
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 207 - 214
  • [37] Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
    Annika Vaclavicek
    Justo Lorenzo Bermejo
    Barbara Wappenschmidt
    Alfons Meindl
    Christian Sutter
    Rita K. Schmutzler
    Marion Kiechle
    Peter Bugert
    Barbara Burwinkel
    Claus R. Bartram
    Kari Hemminki
    Asta Försti
    [J]. Breast Cancer Research and Treatment, 2007, 106 : 205 - 213
  • [38] Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk
    Monsees, Genevieve M.
    Kraft, Peter
    Chanock, Stephen J.
    Hunter, David J.
    Han, Jiali
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 207 - 214
  • [39] Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
    Vaclavicek, Annika
    Bermejo, Justo Lorenzo
    Wappenschmidt, Barbara
    Meindl, Alfons
    Sutter, Christian
    Schmutzler, Rita K.
    Kiechle, Marion
    Bugert, Peter
    Burwinkel, Barbara
    Bartram, Claus R.
    Hemminki, Kari
    Foersti, Asta
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (02) : 205 - 213
  • [40] Genetic variation in sensitivity to estrogens and breast cancer risk
    D. Joseph Jerry
    James D. Shull
    Darryl L. Hadsell
    Monique Rijnkels
    Karen A. Dunphy
    Sallie S. Schneider
    Laura N. Vandenberg
    Prabin Dhangada Majhi
    Celia Byrne
    Amy Trentham-Dietz
    [J]. Mammalian Genome, 2018, 29 : 24 - 37